Brought to you by 
KaloBios brings in $20mm with first close of Series D round
04 Nov 2008
Executive Summary
KaloBios Pharmaceuticals (antibodies) has raised $20mm through the first closing of its Series D venture round. Mitsubishi UFJ Capital and Genzyme Ventures co-led the financing and were joined by current backers MPM Capital, Alloy Ventures, GBS Ventures, Sofinnova Ventures, Singapore Bio-Innovations, 5AM Ventures, and Lotus BioScience Ventures.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
KaloBios brings in $20mm with first close of Series D round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice